By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

BioDelivery Sciences International 

2501 Aerial Center Parkway, Suite 205

Morrisville  North Carolina  27560  U.S.A.
Phone: 919-651-5160 Fax: 919-651-5161


SEARCH JOBS


Industry
Biotechnology

Segment
Drug Delivery





Company News
BioDelivery Sciences International (BDSI) Appoints Charles J. Bramlage And Dr. Barry I. Feinberg To Its Board Of Directors 7/22/2014 1:27:36 PM
Endo International plc (ENDP), BioDelivery Sciences International (BDSI) Painkiller BEMA® Buprenorphine Effective In Phase 3 Study 7/7/2014 6:10:08 AM
BioDelivery Sciences International (BDSI) Announces Completion Of Patient Enrollment In Its Initial Phase 3 Trial Of Clonidine Topical Gel For Painful Diabetic Neuropathy 6/26/2014 6:23:46 AM
BioDelivery Sciences International (BDSI) Featured On Bloomberg TV, Thestreet.Com And Business News Network 6/12/2014 6:26:23 AM
BioDelivery Sciences International (BDSI) To Present At The William Blair And Wells Fargo Healthcare Conferences 6/10/2014 6:17:45 AM
North Carolina's BioDelivery Sciences International (BDSI) Wins FDA Approval For Opiod Dependence Drug Bunavail 6/6/2014 4:41:22 PM
BioDelivery Sciences International (BDSI) Provides Business Review And Update In Conjunction With Filing Of First Quarter 2014 Financials 5/9/2014 6:58:36 AM
BioDelivery Sciences International (BDSI) To Present At The Bank of America (BAC) Merrill Lynch 2014 Health Care Conference 5/8/2014 7:07:49 AM
BioDelivery Sciences International (BDSI) Announces Randomization Of Over 50% Of Subjects In Its Initial Phase 3 Study Of Clonidine Topical Gel For Painful Diabetic Neuropathy 5/6/2014 9:35:59 AM
BioDelivery Sciences International (BDSI) Announces Four BUNAVAIL Abstracts To Be Presented At The 2014 American Society Of Addiction Medicine Annual Conference 4/7/2014 9:27:01 AM
12345678910...
//-->